Two relatively new drugs for type 2 diabetes have been linked to a higher risk of pancreatic cancer. Byetta and Januvia are pricey prescription medications that can cost hundreds of dollars a month. They are used to control blood sugar when other less costly treatments aren’t adequate. Byetta can also help people with diabetes better control their weight. One complication, however, is pancreatitis. Inflammation of the pancreas can be extremely painful and even life threatening.
Now researchers have analyzed the FDA’s adverse event reporting system and found that both drugs nearly triple the risk of pancreatic cancer. This is a very hard-to-treat malignancy. Even though the absolute risk of coming down with pancreatic cancer is small, the prognosis is not good. No one should stop taking either Byetta or Januvia based on this preliminary research, but patients should discuss this potential risk with their physicians.
[Gastroenterology, July, 2011]

Join Over 55,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. cpmt
    Reply

    I am taking Amaryl, does anyone knows or had heard something about this drug? I will really like to know or where to find information. Thank you.

  2. Karen
    Reply

    >They are used to control blood sugar when other less costly treatments aren’t adequate.
    For Type 2 diabetes, when is a low-carb diet NOT adequate?

What Do You Think?

Share your thoughts with others, but be mindful of protecting your own and others' privacy. Not all comments will be posted. Advice from web visitors is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. In posting a comment, you agree to our commenting policy and website terms and conditions.